Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 1,610 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FLD Clear all

Conditions: Prostate Adenocarcinoma, Prostate Cancer
Interventions: Transvesical Single Port Robotic Partial Prostatectomy, High-intensity focused ultrasound (HIFU); Procedure
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 19 Years and older · Male only
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Schizophrenia, Schizo Affective Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Sham Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Fear Extinction
Interventions: Direct intracranial electrical stimulation, Fear conditioning; Other · Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Concussion, Mild
Interventions: Soccer heading; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 26 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Glioblastoma, Glioblastoma Multiforme, Glioma, Astrocytoma, Brain Tumor
Interventions: Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy, Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab; Biological
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Lumbar Disc Disease
Interventions: NOCISCAN-LS Disc MR Spectroscopy; Other
Lead sponsor: Nocimed, LLC; Other
Eligibility: 18 Years to 70 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Muscle Tone Increased
Interventions: High-Intensity Focused Electromagnetic (HIFEM) Field Device; Device
Lead sponsor: BTL Industries Ltd.; Industry
Eligibility: 21 Years and older
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Solana Beach, California

Conditions: Glaucoma Diagnosis
Interventions: Optical Coherence Tomography, Visual evoked potential; Diagnostic Test
Lead sponsor: Wills Eye; Other
Eligibility: 18 Years to 90 Years
Enrollment: 136 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bipolar Depression, Bipolar Disorder, Depression
Interventions: Echo-Planar Magnetic Resonance Imaging (EP-MRSI); Device
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Smoking
Interventions: Repetitive transcranial magnetic stimulation, MagStim Rapid2, Sham repetitive transcranial magnetic stimulation; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Adult Brain Glioblastoma, Recurrent Adult Brain Neoplasm
Interventions: Electric Field Therapy, Bevacizumab, Carmustine, Quality-of-Life Assessment; Procedure · Biological · Drug + 1 more
Lead sponsor: University of California, Davis; Other
Eligibility: 22 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Sacramento, California • Atlanta, Georgia

Conditions: Carotid Atherosclerosis
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: Michael O'Connor; Other
Eligibility: 18 Years to 90 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cognitive Change
Interventions: Neuroblate System; Device
Lead sponsor: Monteris Medical; Industry
Eligibility: 16 Years and older
Enrollment: 81 participants
Timeline: 2021 – 2023
U.S. locations: 7
States / cities: Little Rock, Arkansas • Orlando, Florida • Kansas City, Kansas + 3 more

Conditions: Alzheimer Disease, Primary Progressive Aphasia, Mild Cognitive Impairment
Interventions: repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Paroxysmal Sympathetic Hyperactivity
Interventions: Percutaneous Electrical Nerve Field Stimulation (PENFS) device application; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 2 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Atrial Fibrillation, Catheter Ablation, Autonomic Imbalance
Interventions: Low-level Pulsed EMF, Sham Stimulation; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 21 Years to 85 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Common Warts
Interventions: Nanopulse System; Device
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma
Interventions: Agent Affecting Integumentary System, Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Quality-of-Life Assessment, Questionnaire Administration; Drug · Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 208 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Duarte, California

Conditions: Influenza A, Influenza B
Interventions: QuickVue Influenza A+B; Device
Lead sponsor: Quidel Corporation; Industry
Eligibility: Not listed
Enrollment: 1,381 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 5
States / cities: Phoenix, Arizona • Rochester, New York • Belton, Texas + 2 more

Conditions: Prostate Cancer
Interventions: Standard of Care MRI, Fluciclovine PET scan added to MRI; Device · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Gender Dysphoria
Interventions: Polyethylene Glycol 3350; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Major Depressive Disorder
Interventions: Active Single-Pulse TMS, Sham Single-Pulse TMS, TARGET-optimized TMS, Non-optimized (Open-Loop) TMS, EEG Recording, Intracranial EEG (iEEG) Recording; Device · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 145 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Iowa City, California • Stanford, California

Conditions: PTSD, Alcohol; Use, Problem
Interventions: Seeking Safety + Signs of Safety toolkit, Treatment as usual; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Worcester, Massachusetts

Search by objective public record fields.

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

Amygdala-Prefrontal in Fear Extinction

The Combined Effect of Chronic Cannabis Use and Subconcussive Head Impacts on Brain Health

Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma

NOCISCAN-Lumbar Spine (LS) Clinical Evaluation Study

MRI Evaluation of Change in Gluteal Muscles Following the Treatment With HIFEM Device

How Accurately Does the Diopsys Visual Evoked Potential (VEP) Vision Testing System Detect Glaucoma?

Low Field Magnetic Stimulation Treatment for Bipolar Depression

Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)

Detection of Aggressive Breast Tumors Using Tc-99m-NC100692

PatiEnt Neuropsychological outcomeS After laseR Ablation

Network Modulation in Alzheimer's Disease

Percutaneous Neurostimulation to Treat Paroxysmal Sympathetic Hyperactivity in Children

Low-Level EMF Stimulation for Paroxysmal Atrial Fibrillation

Nanopulse Efficacy Study for the Treatment of Common Warts

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

QuickVue Influenza A + B Test Field Study

Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

Polyethylene-glycol Assisted Nerve Repair in Phalloplasty

Optimizing Brain Excitability in Depression

Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma